300 related articles for article (PubMed ID: 14624489)
1. mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain.
Van Staveren WC; Steinbusch HW; Markerink-Van Ittersum M; Repaske DR; Goy MF; Kotera J; Omori K; Beavo JA; De Vente J
J Comp Neurol; 2003 Dec; 467(4):566-80. PubMed ID: 14624489
[TBL] [Abstract][Full Text] [Related]
2. Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains.
Reyes-Irisarri E; Markerink-Van Ittersum M; Mengod G; de Vente J
Eur J Neurosci; 2007 Jun; 25(11):3332-8. PubMed ID: 17553001
[TBL] [Abstract][Full Text] [Related]
3. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
4. Localization of cyclic guanosine 3',5'-monophosphate-hydrolyzing phosphodiesterase type 9 in rat brain by nonradioactive in situ hydridization.
van Staveren WC; Markerink-van Ittersum M
Methods Mol Biol; 2005; 307():75-84. PubMed ID: 15988056
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells.
Diederen RM; La Heij EC; Markerink-van Ittersum M; Kijlstra A; Hendrikse F; de Vente J
Br J Ophthalmol; 2007 Mar; 91(3):379-84. PubMed ID: 16943225
[TBL] [Abstract][Full Text] [Related]
6. Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain.
van Staveren WC; Glick J; Markerink-van Ittersum M; Shimizu M; Beavo JA; Steinbusch HW; de Vente J
J Neurocytol; 2002; 31(8-9):729-41. PubMed ID: 14501210
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats.
Marte A; Pepicelli O; Cavallero A; Raiteri M; Fedele E
J Neurosci Res; 2008 Nov; 86(15):3338-47. PubMed ID: 18655195
[TBL] [Abstract][Full Text] [Related]
9. Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain.
Reyes-Irisarri E; Pérez-Torres S; Mengod G
Neuroscience; 2005; 132(4):1173-85. PubMed ID: 15857719
[TBL] [Abstract][Full Text] [Related]
10. Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages.
Bender AT; Beavo JA
Neurochem Int; 2004 Nov; 45(6):853-7. PubMed ID: 15312979
[TBL] [Abstract][Full Text] [Related]
11. Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry.
van Staveren WC; Steinbusch HW; Markerink-van Ittersum M; Behrends S; de Vente J
Eur J Neurosci; 2004 Apr; 19(8):2155-68. PubMed ID: 15090042
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period.
Berrendero F; Sepe N; Ramos JA; Di Marzo V; Fernández-Ruiz JJ
Synapse; 1999 Sep; 33(3):181-91. PubMed ID: 10420166
[TBL] [Abstract][Full Text] [Related]
13. Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system.
Feng J; Chang H; Li E; Fan G
J Neurosci Res; 2005 Mar; 79(6):734-46. PubMed ID: 15672446
[TBL] [Abstract][Full Text] [Related]
14. Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases.
Reinhardt RR; Chin E; Zhou J; Taira M; Murata T; Manganiello VC; Bondy CA
J Clin Invest; 1995 Apr; 95(4):1528-38. PubMed ID: 7706458
[TBL] [Abstract][Full Text] [Related]
15. ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):263-74. PubMed ID: 16621444
[TBL] [Abstract][Full Text] [Related]
16. Localization of the scaffolding protein RACK1 in the developing and adult mouse brain.
Ashique AM; Kharazia V; Yaka R; Phamluong K; Peterson AS; Ron D
Brain Res; 2006 Jan; 1069(1):31-8. PubMed ID: 16414032
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane protein 50b (C21orf4), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brain.
Moldrich RX; Lainé J; Visel A; Beart PM; Laffaire J; Rossier J; Potier MC
Neuroscience; 2008 Jul; 154(4):1255-66. PubMed ID: 18541381
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury.
Ranasinghe HS; Williams CE; Christophidis LJ; Mitchell MD; Fraser M; Scheepens A
Neuroscience; 2009 Jan; 158(2):732-44. PubMed ID: 18809469
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.
Gong JP; Onaivi ES; Ishiguro H; Liu QR; Tagliaferro PA; Brusco A; Uhl GR
Brain Res; 2006 Feb; 1071(1):10-23. PubMed ID: 16472786
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?
Albrecht K; Uckert S; Oelke M; Andersson KE; Jonas U; Tröger HD; Hedlund P
J Forensic Leg Med; 2007 Jul; 14(5):270-4. PubMed ID: 17113813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
